{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:01:42Z","timestamp":1777878102580,"version":"3.51.4"},"reference-count":80,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Rare Tumors"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Immunohistochemistry (IHC) provides comprehensive information for morphology and pathologic characteristics and is a valuable tool for establishing the correct cancer diagnosis in clinical diagnostic pathology and determining prognosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    The current study analyzes and compares the expression of Immunohistochemistry biomarkers on neuroendocrine and epithelial cell types of appendiceal neoplasms.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design:<\/jats:bold>\n                    This systematic review adhered to the recommendations in the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. We performed a meta-analysis employing a random effects model with proportions to gauge the proportion of positive cases.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Method:<\/jats:bold>\n                    A comprehensive systematic search in PubMed, Web of Science, and Scopus databases was conducted based on the PRISMA statement up to August 2023. Studies reporting the immunohistochemistry biomarkers expression performed in patients with primary appendiceal neuroendocrine and epithelial cell neoplasms according to the most recent World Health Organization classification of malignant tumors were included.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Our systematic search included 56 observational articles that meet the eligibility criteria. Meta-analysis revealed an expression rate of 93%, 91%, 87%, 71%, 94%, 99%, 32%, 76%, 25%, and 91% for non-specific enolase (NSE), chromaffin A, synaptophysin, Serotonin, SATB2, Caudal-type homeobox 2 (CDX2), \u03b2-catenin, Carcinoembryonic antigen (CEA), Cytokeratin 7, and Cytokeratin 20, respectively. CDX2 and SATB2 were the most expressed markers. The expression rate had a significant association with tumor type. NSE and synaptophysin were the highest in neuroendocrine tumors, whereas CEA was more elevated in gablet cell carcinoids. Cytokeratin 20 is suitable for identifying epithelial cell neoplasms.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The study indicates the proportion of positive cases in patients with primary neuroendocrine and epithelial cell appendiceal neoplasms.\n                  <\/jats:p>","DOI":"10.1177\/20363613251330179","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T11:27:10Z","timestamp":1743679630000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Expression rate and comparison of immunohistochemistry biomarkers in appendiceal neuroendocrine and other epithelial cell neoplasms: Systematic review and meta-analysis"],"prefix":"10.1177","volume":"17","author":[{"given":"Hedieh","family":"Soltani","sequence":"first","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Ahmadinejad","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Shafiee","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Afshar Rezaee","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahya","family":"Beik Mohamadi","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Bahrambeigi","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hossein","family":"Hajialigol","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeedeh","family":"Fattan","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-0095","authenticated-orcid":false,"given":"Javad","family":"Zebarjadi Bagherpour","sequence":"additional","affiliation":[{"name":"Alborz University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"1","key":"e_1_3_6_2_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02236899","article-title":"Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies","volume":"41","author":"Connor SJ","year":"1998","unstructured":"Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum 1998; 41(1): 75\u201380.","journal-title":"Dis Colon Rectum"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200308000-00006"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.5858\/134.6.864"},{"key":"e_1_3_6_6_2","doi-asserted-by":"crossref","first-page":"758643","DOI":"10.3389\/fonc.2021.758643","article-title":"Gastrointestinal goblet cell adenocarcinomas harbor distinctive clinicopathological, immune, and genomic landscape","volume":"11","author":"Lin DL","year":"2021","unstructured":"Lin DL, Wang LL, Zhao P, et al. Gastrointestinal goblet cell adenocarcinomas harbor distinctive clinicopathological, immune, and genomic landscape. Front Oncol 2021; 11: 758643.","journal-title":"Front Oncol"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001159"},{"issue":"2","key":"e_1_3_6_8_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443165","article-title":"ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas)","volume":"103","author":"Pape UF","year":"2016","unstructured":"Pape UF, Niederle B, Costa F, et al. ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas). Neuroendocrinology 2016; 103(2): 144\u2013152.","journal-title":"Neuroendocrinology"},{"issue":"5","key":"e_1_3_6_9_2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/AJCPWW2URZ9JKQJU","article-title":"The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study","volume":"141","author":"Dragomir A","year":"2014","unstructured":"Dragomir A, de Wit M, Johansson C, et al. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study. Am J Clin Pathol 2014; 141(5): 630\u2013638.","journal-title":"Am J Clin Pathol"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31821c3dae"},{"issue":"7","key":"e_1_3_6_11_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4251\/wjgo.v6.i7.253","article-title":"Prevalence and clinicopathological characteristics of appendiceal carcinoids in Sharjah (United Arab Emirates)","volume":"6","author":"Anwar K","year":"2014","unstructured":"Anwar K, Desai M, Al-Bloushi N, et al. Prevalence and clinicopathological characteristics of appendiceal carcinoids in Sharjah (United Arab Emirates). World J Gastrointest Oncol 2014; 6(7): 253\u2013256.","journal-title":"World J Gastrointest Oncol"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01545.x"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31818d7d8b"},{"issue":"7","key":"e_1_3_6_14_2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/his.12899","article-title":"Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours","volume":"68","author":"Strickland S","year":"2016","unstructured":"Strickland S, Parra-Herran C. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours. Histopathology 2016; 68(7): 977\u2013987.","journal-title":"Histopathology"},{"issue":"12","key":"e_1_3_6_15_2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/jcp.2005.035097","article-title":"Expression of \u03b2-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases","volume":"59","author":"Hervieu V","year":"2006","unstructured":"Hervieu V, Lepinasse F, Gouysse G, et al. Expression of \u03b2-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases. J Clin Pathol 2006; 59(12): 1300\u20131304.","journal-title":"J Clin Pathol"},{"issue":"66","key":"e_1_3_6_16_2","first-page":"476","article-title":"[Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients]","volume":"11","author":"Grotowski M","year":"2001","unstructured":"Grotowski M, Maruszy\u0144ski M, Piechota W. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients]. Pol Merkur Lekarski 2001; 11(66): 476\u2013479.","journal-title":"Pol Merkur Lekarski"},{"issue":"2","key":"e_1_3_6_17_2","first-page":"191","article-title":"Co-expression of neuronal intermediate filaments, peripherin and \u03b1-internexin in human well-differentiated endocrine neoplasms (carcinoid tumors) of the appendix","volume":"1","author":"Ishida M","year":"2008","unstructured":"Ishida M, Kushima R, Brevet M, et al. Co-expression of neuronal intermediate filaments, peripherin and \u03b1-internexin in human well-differentiated endocrine neoplasms (carcinoid tumors) of the appendix. Mol Med Rep 2008; 1(2): 191\u2013195.","journal-title":"Mol Med Rep"},{"key":"e_1_3_6_18_2","volume-title":"Cochrane Handbook for systematic reviews of Interventions version 6.3","author":"Higgins JPT","year":"2022","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for systematic reviews of Interventions version 6.3 (updated February 2022). London: Cochrane, 2022."},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906"},{"key":"e_1_3_6_20_2","unstructured":"National Institutes of Health. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. 2014. Available online at: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1985.tb02431.x"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(87)80273-3"},{"issue":"1","key":"e_1_3_6_23_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcp\/94.1.27","article-title":"Goblet cell carcinoids and related tumors of the vermiform appendix","volume":"94","author":"Burke AP","year":"1990","unstructured":"Burke AP, Sobin LH, Federspiel BH, et al. Goblet cell carcinoids and related tumors of the vermiform appendix. Am J Clin Pathol 1990; 94(1): 27\u201335.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"e_1_3_6_24_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2559.1991.tb00815.x","article-title":"Appendiceal goblet cell carcinoids: a clinicopathological and immunohistochemical study","volume":"18","author":"Anderson NH","year":"1991","unstructured":"Anderson NH, Somerville JE, Johnston CF, et al. Appendiceal goblet cell carcinoids: a clinicopathological and immunohistochemical study. Histopathology 1991; 18(1): 61\u201365.","journal-title":"Histopathology"},{"issue":"4","key":"e_1_3_6_25_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2559.1992.tb00992.x","article-title":"The histogenesis of appendiceal carcinoid tumours","volume":"20","author":"Goddard MJ","year":"1992","unstructured":"Goddard MJ, Lonsdale RN. The histogenesis of appendiceal carcinoid tumours. Histopathology 1992; 20(4): 345\u2013349.","journal-title":"Histopathology"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00191345"},{"issue":"3","key":"e_1_3_6_27_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0344-0338(97)80075-1","article-title":"Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins","volume":"193","author":"Le Gall F","year":"1997","unstructured":"Le Gall F, Vallet VS, Thomas D, et al. Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins. Pathol Res Pract 1997; 193(3): 179\u2013185.","journal-title":"Pathol Res Pract"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.28245"},{"issue":"4","key":"e_1_3_6_29_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/path.973","article-title":"Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours","volume":"195","author":"Jakobsen AM","year":"2001","unstructured":"Jakobsen AM, Andersson P, Saglik G, et al. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours. J Pathol 2001; 195(4): 463\u2013472.","journal-title":"J Pathol"},{"issue":"1","key":"e_1_3_6_30_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/EP:13:1:47","article-title":"Expression of E-cadherin, \u03b2-catenin, and Ki-67 in goblet cell carcinoids of the appendix: an immunohistochemical study with clinical correlation","volume":"13","author":"Chiun CL","year":"2002","unstructured":"Chiun CL, Hirokawa M, Zhi RQ, et al. Expression of E-cadherin, \u03b2-catenin, and Ki-67 in goblet cell carcinoids of the appendix: an immunohistochemical study with clinical correlation. Endocr Pathol 2002; 13(1): 47\u201358.","journal-title":"Endocr Pathol"},{"issue":"1","key":"e_1_3_6_31_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/path.1002","article-title":"Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas","volume":"196","author":"Jakobsen AM","year":"2002","unstructured":"Jakobsen AM, Ahlman H, W\u00e4ngberg B, et al. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas. J Pathol 2002; 196(1): 44\u201350.","journal-title":"J Pathol"},{"issue":"4","key":"e_1_3_6_32_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004347-200210000-00009","article-title":"Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas","volume":"21","author":"Ji H","year":"2002","unstructured":"Ji H, Isacson C, Seidman JD, et al. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol 2002; 21(4): 391\u2013400.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"e_1_3_6_33_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jso.20107","article-title":"Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix","volume":"87","author":"Carmignani CP","year":"2004","unstructured":"Carmignani CP, Hampton R, Sugarbaker CE, et al. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol 2004; 87(4): 162\u2013166.","journal-title":"J Surg Oncol"},{"issue":"4","key":"e_1_3_6_34_2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3346\/jkms.2005.20.4.643","article-title":"The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray","volume":"20","author":"Mi JK","year":"2005","unstructured":"Mi JK. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray. J Korean Med Sci 2005; 20(4): 643\u2013648.","journal-title":"J Korean Med Sci"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.08.022"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213281.43036.bb"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800698"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-007-0004-x"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pai.0000210416.53493.0f"},{"issue":"6","key":"e_1_3_6_40_2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2559.2007.02883.x","article-title":"Goblet cell carcinoid of the appendix: a specific type of carcinoma","volume":"51","author":"van Eeden S","year":"2007","unstructured":"van Eeden S, Offerhaus GJ, Hart AA, et al. Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology 2007; 51(6): 763\u2013773.","journal-title":"Histopathology"},{"issue":"3","key":"e_1_3_6_41_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/EJE-08-0196","article-title":"Tachykinins in endocrine tumors and the carcinoid syndrome","volume":"159","author":"Cunningham JL","year":"2008","unstructured":"Cunningham JL, Janson ET, Agarwal S, et al. Tachykinins in endocrine tumors and the carcinoid syndrome. Eur J Endocrinol 2008; 159(3): 275\u2013282.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"e_1_3_6_42_2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/1066896910379404","article-title":"Goblet cell carcinoid of the appendix: a clinicopathological and immunohistochemical study of 26 cases from southwest China","volume":"18","author":"Yong J","year":"2010","unstructured":"Yong J, Huawei L, Hu L, et al. Goblet cell carcinoid of the appendix: a clinicopathological and immunohistochemical study of 26 cases from southwest China. Int J Surg Pathol 2010; 18(6): 488\u2013492.","journal-title":"Int J Surg Pathol"},{"issue":"12","key":"e_1_3_6_43_2","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3182299c25","article-title":"Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases","volume":"35","author":"Chu PG","year":"2011","unstructured":"Chu PG, Chung L, Weiss LM, et al. Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases. Am J Surg Pathol 2011; 35(12): 1830\u20131836.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"e_1_3_6_44_2","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.humpath.2013.06.014","article-title":"CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary","volume":"44","author":"Desouki MM","year":"2013","unstructured":"Desouki MM, Lioyd J, Xu H, et al. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol 2013; 44(11): 2536\u20132541.","journal-title":"Hum Pathol"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117627"},{"issue":"7","key":"e_1_3_6_46_2","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/his.12610","article-title":"Expression of cadherin 17 in well-differentiated neuroendocrine tumours","volume":"66","author":"Snow AN","year":"2015","unstructured":"Snow AN, Mangray S, Lu S, et al. Expression of cadherin 17 in well-differentiated neuroendocrine tumours. Histopathology 2015; 66(7): 1010\u20131021.","journal-title":"Histopathology"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000435"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000553"},{"issue":"3","key":"e_1_3_6_49_2","first-page":"921","article-title":"Expression pattern of cdx2, estrogen and progesterone receptors in primary gastroenteropancreatic neuroendocrine tumors and metastases","volume":"36","author":"Zimmermann N","year":"2016","unstructured":"Zimmermann N, Lazar-Karsten P, Keck T, et al. Expression pattern of cdx2, estrogen and progesterone receptors in primary gastroenteropancreatic neuroendocrine tumors and metastases. Anticancer Res 2016; 36(3): 921\u2013924.","journal-title":"Anticancer Res"},{"issue":"3","key":"e_1_3_6_50_2","first-page":"281","article-title":"Are goblet cell carcinoids a group of heterogeneous tumors? Biomedical papers of the Medical Faculty of the University Palacky","volume":"161","author":"Macak J","year":"2017","unstructured":"Macak J, Nemejcova K, Dvorackova J. Are goblet cell carcinoids a group of heterogeneous tumors? Biomedical papers of the Medical Faculty of the University Palacky. Olomouc, Czechoslovakia 2017; 161(3): 281\u2013285.","journal-title":"Olomouc, Czechoslovakia"},{"issue":"6","key":"e_1_3_6_51_2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EC-18-0059","article-title":"Prognostic value of chromogranin A in patients with GET\/NEN in the pancreas and the small intestine","volume":"7","author":"Fuksiewicz M","year":"2018","unstructured":"Fuksiewicz M, Kowalska M, Kolasi\u0144ska-\u0106wik\u0142a A, et al. Prognostic value of chromogranin A in patients with GET\/NEN in the pancreas and the small intestine. Endocr Connect 2018; 7(6): 803\u2013810.","journal-title":"Endocr Connect"},{"issue":"3","key":"e_1_3_6_52_2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.prp.2017.12.008","article-title":"SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): a series of seven cases","volume":"214","author":"Schmoeckel E","year":"2018","unstructured":"Schmoeckel E, Kirchner T, Mayr D. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): a series of seven cases. Pathol Res Pract 2018; 214(3): 426\u2013430.","journal-title":"Pathol Res Pract"},{"key":"e_1_3_6_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-018-0129-8"},{"issue":"1","key":"e_1_3_6_54_2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1186\/s13104-019-4816-9","article-title":"The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm","volume":"12","author":"Aldaoud N","year":"2019","unstructured":"Aldaoud N, Erashdi M, AlKhatib S, et al. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm. BMC Res Notes 2019; 12(1): 770.","journal-title":"BMC Res Notes"},{"key":"e_1_3_6_55_2","first-page":"100","article-title":"Comparative immunohistochemical staining for chromogranin a and synaptophysin in intestinal carcinoids","volume":"5","author":"Tomita T","year":"2019","unstructured":"Tomita T. Comparative immunohistochemical staining for chromogranin a and synaptophysin in intestinal carcinoids. Int J Pathol Clin Res 2019; 5: 100.","journal-title":"Int J Pathol Clin Res"},{"key":"e_1_3_6_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.13943"},{"key":"e_1_3_6_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.14012"},{"issue":"6","key":"e_1_3_6_58_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ajcp\/aqaa014","article-title":"INSM1 is a highly specific marker of neuroendocrine differentiation in primary neoplasms of the gastrointestinal tract, appendix, and pancreas","volume":"153","author":"McHugh KE","year":"2020","unstructured":"McHugh KE, Mukhopadhyay S, Doxtader EE, et al. INSM1 is a highly specific marker of neuroendocrine differentiation in primary neoplasms of the gastrointestinal tract, appendix, and pancreas. Am J Clin Pathol 2020; 153(6): 811\u2013820.","journal-title":"Am J Clin Pathol"},{"key":"e_1_3_6_59_2","doi-asserted-by":"publisher","DOI":"10.4103\/jpi.jpi_37_20"},{"key":"e_1_3_6_60_2","doi-asserted-by":"crossref","first-page":"102199","DOI":"10.1016\/j.amsu.2021.102199","article-title":"Epidemiology, histopathology, clinical outcomes and survival of 50 cases of appendiceal mucinous neoplasms: retrospective cross-sectional single academic tertiary care hospital experience","volume":"64","author":"Aleter A","year":"2021","unstructured":"Aleter A, El Ansari W, Toffaha A, et al. Epidemiology, histopathology, clinical outcomes and survival of 50 cases of appendiceal mucinous neoplasms: retrospective cross-sectional single academic tertiary care hospital experience. Ann Med Surg 2021; 64: 102199.","journal-title":"Ann Med Surg"},{"issue":"11","key":"e_1_3_6_61_2","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1007\/s11605-021-04953-y","article-title":"The utility of preoperative tumor markers in peritoneal carcinomatosis from primary appendiceal adenocarcinoma: an analysis from the US HIPEC collaborative","volume":"25","author":"Fackche N","year":"2021","unstructured":"Fackche N, Schmocker RK, Kubi B, et al. The utility of preoperative tumor markers in peritoneal carcinomatosis from primary appendiceal adenocarcinoma: an analysis from the US HIPEC collaborative. J Gastrointest Surg 2021; 25(11): 2908\u20132919.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"e_1_3_6_62_2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/SLA.0000000000005026","article-title":"Molecular genomic assessment using a blood-based mRNA signature (NETest) is cost-effective and predicts neuroendocrine tumor recurrence with 94% accuracy","volume":"274","author":"Modlin IM","year":"2021","unstructured":"Modlin IM, Kidd M, Frilling A, et al. Molecular genomic assessment using a blood-based mRNA signature (NETest) is cost-effective and predicts neuroendocrine tumor recurrence with 94% accuracy. Ann Surg 2021; 274(3): 481\u2013490.","journal-title":"Ann Surg"},{"issue":"9","key":"e_1_3_6_63_2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jclinpath-2020-206645","article-title":"Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours","volume":"74","author":"Mohanty SK","year":"2021","unstructured":"Mohanty SK, Tiwari A, Bhardwaj N, et al. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours. J Clin Pathol 2021; 74(9): 582\u2013588.","journal-title":"J Clin Pathol"},{"key":"e_1_3_6_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02906-5"},{"issue":"1","key":"e_1_3_6_65_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5505\/ejm.2023.78309","article-title":"Neuroendocrine tumours detected after appendectomy: 5-year single center experience with 4888 acute appendicitis patients","volume":"28","author":"Ba\u015fkent A","year":"2023","unstructured":"Ba\u015fkent A, Alkan M, Memi\u015fo\u011flu E, et al. Neuroendocrine tumours detected after appendectomy: 5-year single center experience with 4888 acute appendicitis patients. East J Med 2023; 28(1): 179\u2013184.","journal-title":"East J Med"},{"issue":"4","key":"e_1_3_6_66_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5858\/arpa.2021-0317-OA","article-title":"SATB2 expression in human tumors: a tissue microarray study on more than 15 000 tumors","volume":"147","author":"Dum D","year":"2023","unstructured":"Dum D, Kromm D, Lennartz M, et al. SATB2 expression in human tumors: a tissue microarray study on more than 15 000 tumors. Arch Pathol Lab Med 2023; 147(4): 451\u2013464.","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_3_6_67_2","doi-asserted-by":"publisher","DOI":"10.1177\/10668969221095172"},{"issue":"1","key":"e_1_3_6_68_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12957-023-03025-6","article-title":"Analysis of surgical treatment of appendix neuroendocrine neoplasms-17 years of single-center experience","volume":"21","author":"Zhang HW","year":"2023","unstructured":"Zhang HW, Jiang Y, Huang ZY, et al. Analysis of surgical treatment of appendix neuroendocrine neoplasms-17 years of single-center experience. World J Surg Oncol 2023; 21(1): 150.","journal-title":"World J Surg Oncol"},{"key":"e_1_3_6_69_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.085688"},{"key":"e_1_3_6_70_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0243-RS"},{"issue":"3","key":"e_1_3_6_71_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12022-023-09779-9","article-title":"Immunoreactivity of HOXB13 in neuroendocrine neoplasms is a sensitive and specific marker of rectal well-differentiated neuroendocrine tumors","volume":"34","author":"Soukup J","year":"2023","unstructured":"Soukup J, Manethova M, Stejskal V, et al. Immunoreactivity of HOXB13 in neuroendocrine neoplasms is a sensitive and specific marker of rectal well-differentiated neuroendocrine tumors. Endocr Pathol 2023; 34(3): 333\u2013341.","journal-title":"Endocr Pathol"},{"issue":"1","key":"e_1_3_6_72_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12253-010-9291-5","article-title":"Clinicopathological features and immunoexpression profiles of goblet cell carcinoid and typical carcinoid of the appendix","volume":"17","author":"Jiang Y","year":"2011","unstructured":"Jiang Y, Long H, Wang W, et al. Clinicopathological features and immunoexpression profiles of goblet cell carcinoid and typical carcinoid of the appendix. Pathol Oncol Res 2011; 17(1): 127\u2013132.","journal-title":"Pathol Oncol Res"},{"issue":"10","key":"e_1_3_6_73_2","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.5858\/2006-130-1522-EOTITF","article-title":"Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin","volume":"130","author":"Jaffee IM","year":"2006","unstructured":"Jaffee IM, Rahmani M, Singhal MG, et al. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Arch Pathol Lab Med 2006; 130(10): 1522\u20131526.","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_3_6_74_2","doi-asserted-by":"publisher","DOI":"10.1309\/UKN6PVRKXHG422DA"},{"key":"e_1_3_6_75_2","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2021.1881756"},{"issue":"3","key":"e_1_3_6_76_2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jjco\/hyp150","article-title":"CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma","volume":"40","author":"Shin JH","year":"2010","unstructured":"Shin JH, Bae JH, Lee A, et al. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Jpn J Clin Oncol 2010; 40(3): 208\u2013213.","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"e_1_3_6_77_2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/modpathol.2009.74","article-title":"Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: a special reference to classification and predictive factors","volume":"22","author":"Yoon SO","year":"2009","unstructured":"Yoon SO, Kim BH, Lee HS, et al. Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: a special reference to classification and predictive factors. Mod Pathol 2009; 22(8): 1102\u20131112.","journal-title":"Mod Pathol"},{"key":"e_1_3_6_78_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.ijpm_514_23"},{"issue":"2","key":"e_1_3_6_79_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(22)00750-1","article-title":"Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study","volume":"24","author":"Nesti C","year":"2023","unstructured":"Nesti C, Br\u00e4utigam K, Benavent M, et al. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study. Lancet Oncol 2023; 24(2): 187\u2013194.","journal-title":"Lancet Oncol"},{"key":"e_1_3_6_80_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09708-2"},{"issue":"4","key":"e_1_3_6_81_2","doi-asserted-by":"crossref","first-page":"100442","DOI":"10.1016\/j.modpat.2024.100442","article-title":"PITX2 as a sensitive and specific marker of midgut neuroendocrine tumors: results from a cohort of 1157 primary neuroendocrine neoplasms","volume":"37","author":"Grass A","year":"2024","unstructured":"Grass A, Kasajima A, Foersch S, et al. PITX2 as a sensitive and specific marker of midgut neuroendocrine tumors: results from a cohort of 1157 primary neuroendocrine neoplasms. Mod Pathol 2024; 37(4): 100442.","journal-title":"Mod Pathol"}],"container-title":["Rare Tumors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20363613251330179","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20363613251330179","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20363613251330179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:11:54Z","timestamp":1777590714000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20363613251330179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":80,"alternative-id":["10.1177\/20363613251330179"],"URL":"https:\/\/doi.org\/10.1177\/20363613251330179","relation":{},"ISSN":["2036-3613","2036-3613"],"issn-type":[{"value":"2036-3613","type":"print"},{"value":"2036-3613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"article-number":"20363613251330179"}}